Mucosal Immunity
34.5K views | +21 today
Mucosal Immunity
The largest immune tissue in the body
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
March 12, 2023 12:52 PM
Scoop.it!

Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection

Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection | Mucosal Immunity | Scoop.it
Exposure to these bifidobacterial strains protect against the inflammatory sequelae
and damage associated with uncontrolled viral replication within the lung.
No comment yet.
Scooped by Gilbert C FAURE
March 10, 2023 2:17 AM
Scoop.it!

How the brain senses a flu infection — and orders the body to rest

How the brain senses a flu infection — and orders the body to rest | Mucosal Immunity | Scoop.it
Scientists trace the neurons in the throat that sense infections and relay this information to the brain.
No comment yet.
Scooped by Gilbert C FAURE
March 8, 2023 8:25 AM
Scoop.it!

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic | Mucosal Immunity | Scoop.it
ACE2 plays fundamental roles in human physiology and disease. This review summarizes
ACE2’s functions, highlights its relationship with SARS-CoV-2, describes implications
for long COVID, and provides a framework for developing universal therapeutic strategies
against current and future SARS-CoV-2 variants by exploring the ACE2 pathway and interfering
with the spike-ACE2 interaction.
No comment yet.
Scooped by Gilbert C FAURE
March 3, 2023 5:26 AM
Scoop.it!

Can the “world’s first intranasal COVID vaccine” help spur booster uptake in India? | Gavi, the Vaccine Alliance

Can the “world’s first intranasal COVID vaccine” help spur booster uptake in India? | Gavi, the Vaccine Alliance | Mucosal Immunity | Scoop.it
Physicians say they hope the needle-free jab will fuel booster demand, helping squash transmission of the pandemic virus.
No comment yet.
Scooped by Gilbert C FAURE
February 16, 2023 3:56 AM
Scoop.it!

Home Page: Mucosal Immunology

Home Page: Mucosal Immunology | Mucosal Immunity | Scoop.it
Current IssueNovember 2022Volume 15Issue 6 Articles in Press Past Issues Submit article Articles in Press ReviewOpen AccessNecrotizing Enterocolitis in Premature Infants – A Defect in The Brakes? Evidence from Clinical and Animal StudiesSampath et al.Published online: February 15, 2023ArticleOpen AccessRhinovirus C Causes Heterogeneous Infection and Gene Expression in Airway Epithelial Cell SubsetsBasnet et al.Published online: February 14, 2023ArticleOpen AccessATG16L1 protects from IFN-γ-induced cell death in the small intestinal cryptFoerster et al.Published online: February 13, 2023Research ArticleOpen AccessIL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileumBrabec et al.Published online: February 2, 2023View All Collections Covid19 Emerging Leaders Helminth Immunology Mucosal Neuroimmunology Issue Highlights EditorialOpen ArchiveLessons from helminths: what worms have taught us about mucosal immunologyPerona-Wright et al.Published in issue: November, 2022EditorialOpen ArchiveA new age for (mucosal) NeuroImmunologyGerard EberlPublished in issue: November, 2022EditorialOpen ArchiveJohn Bienenstock ObituaryOgra et al.Published in issue: November, 2022CommentOpen AccessMicrobial antigen in human milk: a natural vaccine?van den Elsen et al.Published in issue: November, 2022 Most Read (Last 30 Days) ReviewOpen AccessInitiation of type 2 immunity at barrier surfacesMcDaniel et al.Published online: January 12, 2023Brief reportOpen AccessTissue-resident memory T cells trigger rapid exudation and local antibody accumulationRosato et al.Published online: January 16, 2023ArticleOpen AccessHigh-fat diet-induced resistance to helminth infection via alternative induction of type 2 immunityFunjika et al.Published online: January 20, 2023Review ArticleOpen AccessStromal regulation of the intestinal barrierSylvestre et al.Published online: January 25, 2023Research ArticleOpen AccessIL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileumBrabec et al.Published online: February 2, 2023Brief reportOpen AccessRegulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epitheliumStocker et al.Published online: January 12, 2023 About ## Impact Factor ## CiteScore ## 5-Year Impact Factor 3.98 days Time to Desk Reject 19 days Review Time Submit a Manuscript Most Cited (Previous 3 Years) Tweets by Mucosal Immunology SMI Features
No comment yet.
Scooped by Gilbert C FAURE
February 8, 2023 5:26 AM
Scoop.it!

Breastfeeding 2023

Breastfeeding 2023 | Mucosal Immunity | Scoop.it
Breastfeeding has proven health benefits for both mothers and babies in high-income and low-income settings alike. Yet, less than 50% of babies worldwide are breastfed according to WHO recommendations.
No comment yet.
Rescooped by Gilbert C FAURE from Veille Coronavirus - Covid-19
February 1, 2023 5:02 AM
Scoop.it!

Immunogenicity and Tolerability of BBV154 (iNCOVACC®), an Intranasal SARS-CoV-2 Vaccine, Compared with Intramuscular Covaxin® in Healthy Adults: A Randomised, Open-Label, Phase 3 Clinical Trial by ...

Immunogenicity and Tolerability of BBV154 (iNCOVACC®), an Intranasal SARS-CoV-2 Vaccine, Compared with Intramuscular Covaxin® in Healthy Adults: A Randomised, Open-Label, Phase 3 Clinical Trial by ... | Mucosal Immunity | Scoop.it
Background: Unlike intramuscular vaccines, intranasal COVID-19 vaccines may generate mucosal immunity, which may be critical for to prevent infection and human-

Via HAS-veille
No comment yet.
Scooped by Gilbert C FAURE
January 29, 2023 3:37 AM
Scoop.it!

Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work | Gavi, the Vaccine Alliance

Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work | Gavi, the Vaccine Alliance | Mucosal Immunity | Scoop.it
An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.
No comment yet.
Scooped by Gilbert C FAURE
January 26, 2023 11:27 AM
Scoop.it!

Maryam Diba on LinkedIn: #md_immunol #immunology #circadian #immune #health #immunity #risers…

Maryam Diba on LinkedIn: #md_immunol #immunology #circadian #immune #health #immunity #risers… | Mucosal Immunity | Scoop.it
The circadian immune system



👉🛑In addition to the many great benefits, early risers also bring the highest level of immune activity.


👉…
No comment yet.
Scooped by Gilbert C FAURE
January 24, 2023 3:41 AM
Scoop.it!

Type II taste cells participate in mucosal immune surveillance | PLOS Biology

Type II taste cells participate in mucosal immune surveillance | PLOS Biology | Mucosal Immunity | Scoop.it
The oral microbiome is second only to its intestinal counterpart in diversity and abundance, but its effects on taste cells remains largely unexplored. Using single-cell RNASeq, we found that mouse taste cells, in particular, sweet and umami receptor cells that express taste 1 receptor member 3...
No comment yet.
Scooped by Gilbert C FAURE
January 23, 2023 2:43 AM
Scoop.it!

Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota

Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota | Mucosal Immunity | Scoop.it
Establishing and maintaining tolerance to self-antigens or innocuous foreign antigens is vital for the preservation of organismal health. Within the thymus, medullary thymic epithelial cells (mTECs) expressing autoimmune regulator (AIRE) have a critical role in self-tolerance through deletion of autoreactive T cells and promotion of thymic regulatory T (Treg) cell development1–4. Within weeks of birth, a separate wave of Treg cell differentiation occurs in the periphery upon exposure to antigens derived from the diet and commensal microbiota5–8, yet the cell types responsible for the generation of peripheral Treg (pTreg) cells have not been identified. Here we describe the identification of a class of RORγt+ antigen-presenting cells called Thetis cells, with transcriptional features of both mTECs and dendritic cells, comprising four major sub-groups (TC I–TC IV). We uncover a developmental wave of Thetis cells within intestinal lymph nodes during a critical window in early life, coinciding with the wave of pTreg cell differentiation. Whereas TC I and TC III expressed the signature mTEC nuclear factor AIRE, TC IV lacked AIRE expression and was enriched for molecules required for pTreg generation, including the TGF-β-activating integrin αvβ8. Loss of either major histocompatibility complex class II (MHCII) or ITGB8 by Thetis cells led to a profound impairment in intestinal pTreg differentiation, with ensuing colitis. By contrast, MHCII expression by RORγt+ group 3 innate lymphoid cells (ILC3) and classical dendritic cells was neither sufficient nor required for pTreg generation, further implicating TC IV as the tolerogenic RORγt+ antigen-presenting cell with an essential function in early life. Our studies reveal parallel pathways for the establishment of tolerance to self and foreign antigens in the thymus and periphery, respectively, marked by the involvement of shared cellular and transcriptional programmes. Single-cell transcriptomic and epigenetic analysis has enabled the identification of Thetis cells, a class of RORγt+ antigen-presenting cells with a key role in the differentiation of commensal microbiota-induced peripheral regulatory T cells.
No comment yet.
Scooped by Gilbert C FAURE
January 20, 2023 10:18 AM
Scoop.it!

Rokote Laboratories Finland Ltd is probably the only company in Europe developing a nasal COVID-19 vaccine – the administration method brings substantial benefits to combating the disease

Rokote Laboratories Finland Ltd is probably the only company in Europe developing a nasal COVID-19 vaccine – the administration method brings substantial benefits to combating the disease | Mucosal Immunity | Scoop.it
The nasal vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.
Gilbert C FAURE's insight:

https://www.univ-tours.fr/recherche/animer-la-recherche/nos-unites-de-recherche/umr-1282-infectiologie-et-sante-publique-isp

No comment yet.
Scooped by Gilbert C FAURE
January 18, 2023 10:16 AM
Scoop.it!

Developing mucosal vaccines for respiratory viruses

Developing mucosal vaccines for respiratory viruses | Mucosal Immunity | Scoop.it
NIH experts offer perspective on next-generation approaches.
No comment yet.
Scooped by Gilbert C FAURE
March 10, 2023 2:35 AM
Scoop.it!

Frontiers | Immunoregulation by antigen-presenting cells in human intestinal lamina propria

Frontiers | Immunoregulation by antigen-presenting cells in human intestinal lamina propria | Mucosal Immunity | Scoop.it
Antigen-presenting cells, including macrophages and dendritic cells, are a type of innate immune cells that can induce the differentiation of T cells and activate the adaptive immune response. In recent years, diverse subsets of macrophages and dendritic cells have been identified in the intestinal lamina propria of mice and humans. These subsets contribute to the maintenance of intestinal tissue homeostasis by regulating the adaptive immune system and epithelial barrier function through interaction with intestinal bacteria. Further investigation of the roles of antigen-presenting cells localized in the intestinal tract may lead to the elucidation of inflammatory bowel disease pathology and the development of novel treatment approaches.
No comment yet.
Scooped by Gilbert C FAURE
March 9, 2023 12:33 PM
Scoop.it!

Frontiers | Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders

Frontiers | Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders | Mucosal Immunity | Scoop.it
IntroductionCurrent approved COVID-19 vaccines, notably mRNA and adenoviral vectored technologies, still fail to fully protect against infection and transmission of various SARS-CoV-2 variants. The mucosal immunity at the upper respiratory tract represents the first line of defense against respiratory viruses such as SARS-CoV-2 and is thus critical to develop vaccine blocking human-to-human transmission.MethodsWe measured systemic and mucosal Immunoglobulin A (IgA) response in serum and saliva from 133 healthcare workers from Percy teaching military hospital following a mild infection (SARS-CoV-2 Wuhan strain, n=58) or not infected (n=75), and after SARS-CoV-2 vaccination (Vaxzevria®/Astrazeneca and/or Comirnaty®/Pfizer).ResultsWhile serum anti-SARS-CoV-2 Spike IgA response lasted up to 16 months post-infection, IgA response in saliva had mostly fallen to baseline level at 6 months post-infection. Vaccination could reactivate the mucosal response generated by prior infection, but failed to induce a significant mucosal IgA response by itself. Early post-COVID-19 serum anti-Spike-NTD IgA titer correlated with seroneutralization titers. Interestingly, its saliva counterpart positively correlated with persistent smell and taste disorders more than one year after mild COVID-19.DiscussionAs breakthrough infections have been correlated with IgA levels, other vaccine platforms inducing a better mucosal immunity are needed to control COVID-19 infection in the future. Our result
No comment yet.
Scooped by Gilbert C FAURE
March 3, 2023 5:28 AM
Scoop.it!

Increased NKG2A+CD8+ T-cell exhaustion in patients with adenomyosis

Increased NKG2A+CD8+ T-cell exhaustion in patients with adenomyosis | Mucosal Immunity | Scoop.it
Immune dysregulation has long been proposed to be associated with adenomyosis, but
the underlying mediators and mechanisms remain largely unexplored. Here, we used flow
cytometry to investigate the alterations in immune cell subsets in adenomyotic uteri
and analyze the phenotype and function of abnormal immune cells. We found that an
increase in CD8+ T-cell number was the predominant alteration in ectopic lesions in
patients with adenomyosis and was significantly associated with the severity of adenomyosis.
No comment yet.
Scooped by Gilbert C FAURE
February 22, 2023 6:11 AM
Scoop.it!

Frontiers | Emerging role for interferons in respiratory viral infections and childhood asthma

Frontiers | Emerging role for interferons in respiratory viral infections and childhood asthma | Mucosal Immunity | Scoop.it
Respiratory syncytial virus (RSV) and Rhinovirus (RV) infections are major triggers of severe lower respiratory illnesses (sLRI) in infants and children and are strongly associated with the subsequent development of asthma. Decades of research has focused on the role of type I interferons in antiviral immunity and ensuing airway diseases, however, recent findings have highlighted several novel aspects of the interferon response that merit further investigation. In this perspective, we discuss emerging roles of type I interferons in the pathogenesis of sLRI in children. We propose that variations in interferon response patterns exist as discrete endotypes, which operate locally in the airways and systemically through a lung-blood-bone marrow axis. We discuss new insights into the role of interferons in immune training, bacterial lysate immunotherapy, and allergen-specific immunotherapy. Interferons play complex and diverse roles in the pathogenesis of sLRI and later asthma, providing new directions for mechanistic studies and drug development.
No comment yet.
Scooped by Gilbert C FAURE
February 11, 2023 4:23 AM
Scoop.it!

The World of Chinese on LinkedIn: From a murdered concubine, to a literati's muse, to a forgotten deity…

The World of Chinese on LinkedIn: From a murdered concubine, to a literati's muse, to a forgotten deity… | Mucosal Immunity | Scoop.it
From a murdered concubine, to a literati's muse, to a forgotten deity, "Toilet Goddess," or Zigu (紫姑, “the Purple Lady”), is among China's most underrated…
No comment yet.
Scooped by Gilbert C FAURE
February 3, 2023 2:53 AM
Scoop.it!

person to person microbiome sharing.... https://www.nature.com/articles/s41586-022-05620-1https://www.sciencedirect.com/science/article/pii/S0092867422015811

No comment yet.
Scooped by Gilbert C FAURE
January 31, 2023 5:22 AM
Scoop.it!

Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children | Nature Immunology

Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children | Nature Immunology | Mucosal Immunity | Scoop.it
Most studies of adaptive immunity to SARS-CoV-2 infection focus on peripheral blood, which may not fully reflect immune responses at the site of infection. Using samples from 110 children undergoing tonsillectomy and adenoidectomy during the COVID-19 pandemic, we identified 24 samples with evidence of previous SARS-CoV-2 infection, including neutralizing antibodies in serum and SARS-CoV-2-specific germinal center and memory B cells in the tonsils and adenoids. Single-cell B cell receptor (BCR) sequencing indicated virus-specific BCRs were class-switched and somatically hypermutated, with overlapping clones in the two tissues. Expanded T cell clonotypes were found in tonsils, adenoids and blood post-COVID-19, some with CDR3 sequences identical to previously reported SARS-CoV-2-reactive T cell receptors (TCRs). Pharyngeal tissues from COVID-19-convalescent children showed persistent expansion of germinal center and antiviral lymphocyte populations associated with interferon (IFN)-γ-type responses, particularly in the adenoids, and viral RNA in both tissues. Our results provide evidence for persistent tissue-specific immunity to SARS-CoV-2 in the upper respiratory tract of children after infection. Manthiram and colleagues analyze the peripheral blood, tonsils and adenoids in children undergoing tonsillectomy or adenoidectomy and find evidence of continued tissue-specific immunity to SARS-CoV-2 and viral RNA persistence weeks to months after acute infection.
No comment yet.
Scooped by Gilbert C FAURE
January 26, 2023 1:53 PM
Scoop.it!

Microorganisms | Free Full-Text | The Gut Microbiome of Children during the COVID-19 Pandemic

Microorganisms | Free Full-Text | The Gut Microbiome of Children during the COVID-19 Pandemic | Mucosal Immunity | Scoop.it
The gut microbiome has been shown to play a critical role in maintaining a healthy state. Dysbiosis of the gut microbiome is involved in modulating disease severity and potentially contributes to long-term outcomes in adults with COVID-19.
No comment yet.
Scooped by Gilbert C FAURE
January 24, 2023 3:41 AM
Scoop.it!

Taste Cells’ Role in Immune Response May Lead to Treatment of Taste Loss

Taste Cells’ Role in Immune Response May Lead to Treatment of Taste Loss | Mucosal Immunity | Scoop.it
A subset of taste cells may play a key role in the body's immune response to harmful oral microbes. The findings could help taste loss associated with infections, aging, and dysregulation of the oral microbiome caused by chemotherapy.
No comment yet.
Scooped by Gilbert C FAURE
January 24, 2023 3:40 AM
Scoop.it!

Researchers Are Working on a Needle-Free 'Drinkable' COVID-19 Vaccine | Weather.com

Researchers Are Working on a Needle-Free 'Drinkable' COVID-19 Vaccine | Weather.com | Mucosal Immunity | Scoop.it
Unlike traditional vaccines, mucosal vaccines enter through our mucous membranes, either through our nose or through our gut .- Articles from The Weather Channel | weather.com...
No comment yet.
Scooped by Gilbert C FAURE
January 20, 2023 10:19 AM
Scoop.it!

A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice. | Research Square

Multiple FDA-approved SARS-CoV-2 vaccines provide excellent protection against severe disease. Despite this, immunity can wane relatively fast, particularly in the elderly and novel viral variants capable of evading infection- and vaccination-induced immunity continue to emerge.
No comment yet.
Scooped by Gilbert C FAURE
January 20, 2023 6:32 AM
Scoop.it!

Inflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation | Nature Communications

Inflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation | Nature Communications | Mucosal Immunity | Scoop.it
Inflammatory and infectious upper respiratory diseases (ICD-10: J30-J39), such as diseases of the sinonasal tract, pharynx and larynx, are growing health problems yet their genomic similarity is not known. We analyze genome-wide association to eight upper respiratory diseases (61,195 cases) among 260,405 FinnGen participants, meta-analyzing diseases in four groups based on an underlying genetic correlation structure. Aiming to understand which genetic loci contribute to susceptibility to upper respiratory diseases in general and its subtypes, we detect 41 independent genome-wide significant loci, distinguishing impact on sinonasal or pharyngeal diseases, or both. Fine-mapping implicated non-synonymous variants in nine genes, including three linked to immune-related diseases. Phenome-wide analysis implicated asthma and atopic dermatitis at sinonasal disease loci, and inflammatory bowel diseases and other immune-mediated disorders at pharyngeal disease loci. Upper respiratory diseases also genetically correlated with autoimmune diseases such as rheumatoid arthritis, autoimmune hypothyroidism, and psoriasis. Finally, we associated separate gene pathways in sinonasal and pharyngeal diseases that both contribute to type 2 immunological reaction. We show shared heritability among upper respiratory diseases that extends to several immune-mediated diseases with diverse mechanisms, such as type 2 high inflammation. The shared genetics between upper respiratory diseases have not been well studied. Here, the authors find shared and distinct genetic loci for pharyngeal and sinonasal inflammatory conditions, which show shared heritability with autoimmune conditions and immune deficiency, highlighting the TNFR2 pathway.
No comment yet.